Literature DB >> 1104749

Experimental amyloidosis: the inducer is a polyclonal B-cell activator to which susceptibility is under genetic control.

S Britton.   

Abstract

Experimental amyloidosis in mice can be induced by repeated injections of casein. It has now been demonstrated that casein induces strong polyclonal antibody synthesis in mouse B spleen lymphocytes. This effect is much more pronounced in spleen cells from anyloid-susceptible mice (CBA/J) than amyloid-resistant mice (A/J). It is suggested that amyloidosis can be due in some instances to a constant exposure for molecules which induce polyclonal B-cell activation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1104749      PMCID: PMC2190064          DOI: 10.1084/jem.142.6.1564

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Selective triggering of B cell subpopulations by mitogens.

Authors:  E Gronowicz; A Coutinho
Journal:  Eur J Immunol       Date:  1974-11       Impact factor: 5.532

2.  Mitogens as probes for immunocyte activation and cellular cooperation.

Authors:  J Andersson; O Sjöberg; G Möller
Journal:  Transplant Rev       Date:  1972

3.  Genetic control of host responses to endotoxin.

Authors:  B M Sultzer
Journal:  Infect Immun       Date:  1972-01       Impact factor: 3.441

4.  Suppressor T cells.

Authors:  R K Gershon; P Cohen; R Hencin; S A Liebhaber
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

5.  "Spontaneous" B cell activation due to loss of normal mouse serum suppressor.

Authors:  W W Bullock; E Möller
Journal:  Eur J Immunol       Date:  1972-12       Impact factor: 5.532

Review 6.  Current concepts of amyloid.

Authors:  E C Franklin; D Zucker-Franklin
Journal:  Adv Immunol       Date:  1972       Impact factor: 3.543

Review 7.  Impaired immunity in the etiology of amyloidosis: a speculative review.

Authors:  T J Muckle
Journal:  Isr J Med Sci       Date:  1968 Sep-Oct

8.  Quantitative studies on the decay of lymphoid cells during the development of casein-induced murine amyloidosis.

Authors:  M H Claesson; F Hardt
Journal:  Acta Pathol Microbiol Scand A       Date:  1972

9.  Effect of the number of haptens coupled to each erythrocyte on haemolytic plaque formation.

Authors:  V J Pasanen; O Mäkelä
Journal:  Immunology       Date:  1969-03       Impact factor: 7.397

10.  Casein-induced experimental amyloidosis. III. Response to mitogens, allogeneic cells, and graft-versus-host reactions in the murine model.

Authors:  M A Scheinberg; E S Cathcart
Journal:  Immunology       Date:  1974-11       Impact factor: 7.397

View more
  6 in total

Review 1.  New concepts in the pathogenesis of primary and secondary amyloid disease.

Authors:  M A Scheinberg; E S Cathcart
Journal:  Clin Exp Immunol       Date:  1978-07       Impact factor: 4.330

2.  Lymphoid cells in endotoxin-induced production of the amyloid-related serum amyloid A protein.

Authors:  D L Rosenstreich; K P McAdam
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

3.  Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strains.

Authors:  M L Baltz; K Gomer; A J Davies; D J Evans; G G Klaus; M B Pepys
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

4.  Life span, leukaemia and amyloid incidences of untreated and polycation-treated AKR mice.

Authors:  P Ebbesen
Journal:  Br J Cancer       Date:  1978-01       Impact factor: 7.640

Review 5.  Amyloids in Site-Specific Autoimmune Reactions and Inflammatory Responses.

Authors:  Yan-Mei Huang; Xue-Zhi Hong; Jian Shen; Li-Jun Geng; Yan-Hong Pan; Wei Ling; Hai-Lu Zhao
Journal:  Front Immunol       Date:  2020-01-09       Impact factor: 7.561

6.  Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein.

Authors:  K P McAdam; J D Sipe
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.